Dawn M. Flaherty

1.5k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Dawn M. Flaherty is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dawn M. Flaherty has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Dawn M. Flaherty's work include Virus-based gene therapy research (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Dawn M. Flaherty is often cited by papers focused on Virus-based gene therapy research (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Dawn M. Flaherty collaborates with scholars based in United States, Türkiye and Singapore. Dawn M. Flaherty's co-authors include Garry R. Buettner, Yunxia O’Malley, S. L. Hempel, Martha M. Monick, Gary W. Hunninghake, Michael W. Peterson, A. Brent Carter, Linda S. Powers, Thomas Groß and Rama K. Mallampalli and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Dawn M. Flaherty

15 papers receiving 1.3k citations

Hit Papers

Dihydrofluorescein diacetate is superior for detecting in... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn M. Flaherty United States 13 668 298 181 142 115 15 1.3k
Antonina Azzolina Italy 28 916 1.4× 416 1.4× 145 0.8× 229 1.6× 201 1.7× 53 2.0k
Carina L. Bos Netherlands 14 473 0.7× 205 0.7× 92 0.5× 141 1.0× 212 1.8× 17 1.4k
Peter K.M. Kim United States 17 867 1.3× 228 0.8× 341 1.9× 153 1.1× 141 1.2× 21 1.5k
S. L. Hempel United States 11 401 0.6× 181 0.6× 224 1.2× 113 0.8× 72 0.6× 17 1.2k
Lucia Trevisi Italy 20 567 0.8× 212 0.7× 115 0.6× 103 0.7× 137 1.2× 43 1.2k
Ewa Witort Italy 20 1.1k 1.6× 198 0.7× 89 0.5× 140 1.0× 132 1.1× 33 1.7k
Anna Caselli Italy 23 1.2k 1.8× 305 1.0× 282 1.6× 265 1.9× 166 1.4× 51 1.9k
Hyoung-Chin Kim South Korea 23 648 1.0× 156 0.5× 105 0.6× 132 0.9× 122 1.1× 77 1.7k
Mirosław Soszyński Poland 18 508 0.8× 169 0.6× 346 1.9× 74 0.5× 103 0.9× 55 1.2k
Yunxia O’Malley United States 18 1.2k 1.7× 163 0.5× 244 1.3× 295 2.1× 109 0.9× 30 1.9k

Countries citing papers authored by Dawn M. Flaherty

Since Specialization
Citations

This map shows the geographic impact of Dawn M. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn M. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn M. Flaherty more than expected).

Fields of papers citing papers by Dawn M. Flaherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn M. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn M. Flaherty. The network helps show where Dawn M. Flaherty may publish in the future.

Co-authorship network of co-authors of Dawn M. Flaherty

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn M. Flaherty. A scholar is included among the top collaborators of Dawn M. Flaherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn M. Flaherty. Dawn M. Flaherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Monick, Martha M., et al.. (2006). Active ERK Contributes to Protein Translation by Preventing JNK-Dependent Inhibition of Protein Phosphatase 1. The Journal of Immunology. 177(3). 1636–1645. 47 indexed citations
2.
Flaherty, Dawn M., et al.. (2005). Human Alveolar Macrophages Are Deficient in PTEN. Journal of Biological Chemistry. 281(8). 5058–5064. 25 indexed citations
3.
Monick, Martha M., Rama K. Mallampalli, Diann M. McCoy, et al.. (2004). Cooperative Prosurvival Activity by ERK and Akt in Human Alveolar Macrophages is Dependent on High Levels of Acid Ceramidase Activity. The Journal of Immunology. 173(1). 123–135. 43 indexed citations
4.
Flaherty, Dawn M., et al.. (2004). Adenovirus vectors activate survival pathways in lung epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 287(2). L393–L401. 25 indexed citations
5.
He, Tongrong, Neal L. Weintraub, Prabhat C. Goswami, et al.. (2003). Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H804–H812. 38 indexed citations
6.
Flaherty, Dawn M., Martha M. Monick, A. Brent Carter, Michael W. Peterson, & Gary W. Hunninghake. (2002). Oxidant-Mediated Increases in Redox Factor-1 Nuclear Protein and Activator Protein-1 DNA Binding in Asbestos-Treated Macrophages. The Journal of Immunology. 168(11). 5675–5681. 37 indexed citations
7.
Doerschug, Kevin C., Salih Şanlıoğlu, Dawn M. Flaherty, et al.. (2002). First-Generation Adenovirus Vectors Shorten Survival Time in a Murine Model of Sepsis. The Journal of Immunology. 169(11). 6539–6545. 25 indexed citations
8.
Monick, Martha M., Noah S. Butler, Dawn M. Flaherty, et al.. (2002). Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA. Journal of Biological Chemistry. 277(36). 32992–33000. 80 indexed citations
9.
Rooney, Cyril P., Gerene M. Denning, Benjamin P. Davis, et al.. (2002). Bronchoalveolar Fluid Is Not a Major Hindrance to Virus-Mediated Gene Therapy in Cystic Fibrosis. Journal of Virology. 76(20). 10437–10443. 8 indexed citations
10.
Monick, Martha M., Rama K. Mallampalli, Dawn M. Flaherty, et al.. (2001). Ceramide Regulates Lipopolysaccharide-Induced Phosphatidylinositol 3-Kinase and Akt Activity in Human Alveolar Macrophages. The Journal of Immunology. 167(10). 5977–5985. 57 indexed citations
11.
Monick, Martha M., et al.. (2001). Lipopolysaccharide Activates Akt in Human Alveolar Macrophages Resulting in Nuclear Accumulation and Transcriptional Activity of β-Catenin. The Journal of Immunology. 166(7). 4713–4720. 161 indexed citations
12.
Flaherty, Dawn M., et al.. (2001). GM-CSF Increases AP-1 DNA Binding and Ref-1 Amounts in Human Alveolar Macrophages. American Journal of Respiratory Cell and Molecular Biology. 25(2). 254–259. 15 indexed citations
13.
Monick, Martha M., A. Brent Carter, Dawn M. Flaherty, Michael W. Peterson, & Gary W. Hunninghake. (2000). Protein Kinase C ζ Plays a Central Role in Activation of the p42/44 Mitogen-Activated Protein Kinase by Endotoxin in Alveolar Macrophages. The Journal of Immunology. 165(8). 4632–4639. 117 indexed citations
14.
Hempel, S. L., et al.. (1999). Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123 - implications for intracellular measurement of reactive nitrogen species. Free Radical Biology and Medicine. 146–159. 1 indexed citations
15.
Hempel, S. L., et al.. (1999). Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radical Biology and Medicine. 27(1-2). 146–159. 665 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026